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Introduction
Panic disorder (PD) is a highly prevalent and debilitating condi-
tion characterized by recurrent, unexpected panic attacks (PAs) 
(American Psychiatric Association, 2013). Based on clinical and 
epidemiological data, a division in subtypes is made, with pre-
dominant respiratory or cardiovascular symptoms compromising 
a “core panic type” (Roberson-Nay and Kendler, 2011). PD is 
associated with high healthcare costs (Batelaan et al., 2007) and 
in spite of available treatments, long-term effects are modest and 
relapse rates are high (Yonkers et al., 2003). Insight into the 
molecular and genetic mechanisms of the disorder would argua-
bly be beneficial in the search for improved and new treatments.
Until recently, genetic research into PD has been relatively 
scarce and less successful compared to other psychiatric disor-
ders (Smoller, 2011). Inspired by previous work in mice, atten-
tion has been turned to the amiloride-sensitive cation channel 2 
(ACCN2), the human homologue to the rodent acid-sensing ion 
channel 1a (ASIC1a). ASIC1a was shown to play an important 
role in conditioned fear (Wemmie et al., 2003, 2004), but the 
interest in ASIC1a in relation to PD was boosted by a seminal 
study (Ziemann et al., 2009) showing that ASIC1a is also essen-
tially involved in the unconditioned behavioral fear response to 
carbon dioxide (CO2) exposure by acting as a chemosensor that 
detects a decrease in extracellular pH.
Analogs can be drawn to humans, in whom CO2 exposure has 
proven to be a reliable experimental model for panic. PD patients 
display a higher fear and panic response to CO2 when compared 
to healthy volunteers (Griez et al., 1987, 1990). A brief inhalation 
of 35% CO2 triggers short lasting, but intense symptoms resem-
bling the ones of a naturally occurring PA in PD patients (Nardi 
et al., 2006; Schruers et al., 2004). We proposed that an acutely 
disturbed acid–base homeostasis represents the mechanism 
underlying the occurrence of PAs (Esquivel et al., 2009), thereby 
forming the molecular basis of the suffocation false alarm theory 
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Until recently, genetic research into panic disorder (PD) has had only limited success. Inspired by rodent research, demonstrating that the acid-sensing 
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(Klein, 1993; Preter and Klein, 2008). CO2 exposure was shown 
to cause a decrease in brain pH in rodents (Schuchmann et al., 
2006; Ziemann et al., 2008, 2009). While studies investigating 
the direct effects of breathing CO2 on brain pH in humans are 
lacking, indirect evidence for brain acidification comes from a 
study using intravenous infusion of bicarbonate, which caused a 
decrease in brain pH as shown by magnetic resonance spectros-
copy (Nakashima et al., 1996). The acid–base homeostasis is 
tightly regulated within a narrow range and a shift out of the nor-
mal range can have fatal consequences (Rhoades and Bell, 2009). 
Therefore, sensing a change in pH and triggering adaptive physi-
ological and behavioral responses are of crucial importance for 
an individual’s survival. Hence, genes encoding for molecules 
involved in chemosensation such as ACCN2 present a pivotal 
link between pH and panic.
To date, only a few studies investigated the link between 
ACCN2 and PD. In a first study (Hettema et al., 2008), the 
C-allele of the single nucleotide polymorphisms rs685012, 
located in the 5′ putative promoter region, was associated with 
anxiety disorder. The replication of this association failed, how-
ever, in a second larger sample. This is probably due to assessing 
a group of mixed anxiety disorder patients of whom only a subset 
had PD. In a large case-control study, Smoller and colleagues 
(2014) demonstrated that the C-allele of rs685012 and of 
rs10875995, located in intron 3, was associated with increased 
probability of having the diagnosis of PD. Similarly, a significant 
increase in the frequency of the rs685012 C-allele in PD patients 
was recently reported by Gugliandolo et al. (2016). In healthy 
volunteers, Smoller et al. (2014) observed that the C-allele was 
associated with a larger amygdala volume and heightened amyg-
dala reactivity to visual presentation of fearful and angry faces.
The proposed mechanism linking ACCN2 and panic in humans 
involves an altered threshold for sensing acidosis (Smoller et al., 
2014). More specifically, variants in the ACCN2 gene may lead to 
a lower threshold for detecting a decrease in pH, resulting in a 
heightened sensitivity to cues from within the body (caused by, 
e.g. CO2 exposure). This mechanism is highly plausible, but 
experimental evidence linking differential CO2 reactivity in 
humans to variants in the ACCN2 gene is currently lacking. For 
many years it was assumed that, in contrast to PD patients, healthy 
volunteers are not sensitive to breathing CO2 (Griez et al., 1987). 
However, by now, a dose-response relationship between CO2 and 
reported fear and bodily symptoms has been repetitively shown 
(Griez et al., 2007; Schruers et al., 2011), whereby a double inha-
lation of 35% CO2 elicits a response that closely resembles the 
one reported by PD patients to a single vital capacity inhalation. 
These observations imply the existence of a CO2-reactivity con-
tinuum and that panic symptoms can be provoked in most indi-
viduals, depending on the concentration of CO2 used. The findings 
suggest that CO2 inhalation activates basic fear mechanisms that 
are present in every individual. This opens the avenue of studying 
panic-related fear in healthy volunteers, thus bridging the gap 
between animal models and research in PD patients.
The present study sought to investigate the relationship 
between the response to CO2 and the ACCN2 gene, with a focus 
on the two gene variants previously found to be associated with 
PD and amygdala reactivity. In the first study, we assessed the 
response to CO2 in healthy individuals. To capture the emotional 
and the physiological reactivity, we examined the effects of CO2 
on self-reported emotions as well as the cardiovascular system. 
In the second study, in light of clinical relevance, the self-reported 
emotional response to CO2 was evaluated in PD patients.
Experimental procedures
Study 1: healthy individuals
Subjects. One-hundred and seven Caucasian adult healthy volun-
teers participated in this study (mean age 23.76 years, SD = 6.96; 27 
males; part of a previous sample (Leibold et al., 2013)). Subjects 
were recruited via advertisements at Maastricht University, the 
Netherlands. Eligibility was confirmed using a standard medical 
examination and a semi-structured psychiatric interview including 
the Mini International Neuropsychiatric Interview (MINI, Sheehan 
et al., 1998), performed by an experienced psychiatrist or psycholo-
gist. Exclusion criteria included current or past cardiovascular 
or pulmonary disease, hypertension (systolic/diastolic >170/100 
mmHg), familial or personal history of cerebral aneurysm, smoking 
(>15 cigarettes per day), pregnancy, epilepsy, use of psychotropic 
medication or adrenergic receptor blockers, and a first-degree rela-
tive with PD. All participants gave written informed consent prior to 
the study. The study was approved by the Medical Ethics Committee 
of Maastricht University and the Maastricht University Hospital.
CO2 inhalation. The standardized protocol for CO2 inhalations in 
healthy volunteers has been described previously (Griez et al., 
2007). In brief, subjects were informed that CO2 might cause some 
effects, ranging from minor sensations up to fear. However, all 
effects would be short-lasting. Subjects took a double vital capacity 
breath of 35% CO2. All subjects inhaled at least 80% of their vital 
capacity as measured using a flowmeter. Subjects were instructed to 
refrain from caffeine containing beverages on all inhalation days.
Self-reports. The affective response to CO2 was evaluated in 
accordance with the DSM-IV criteria for a PA (American Psychi-
atric Association, 2000). Fear and discomfort were assessed using 
the Visual Analogue Scale (VAS-F and VAS-D, respectively), 
consisting of a horizontal line of 100 mm length and ranging from 
0 (not at all) to 100 (the worst imaginable). Panic symptomatol-
ogy was evaluated using the panic symptom list (PSL), a ques-
tionnaire listing the 13 DSM PA symptoms such as palpitations, 
sweating, shortness of breath, dizziness, and choking, and ranging 
from 0 (absent) to 4 (very intense). Self-reports were obtained 
directly before and immediately after the inhalation.
Cardiovascular recordings. Blood pressure and heart rate were 
measured continuously throughout the entire procedure in 
healthy volunteers using a computerized system (Carbon Dioxide 
Tolerance Tester, CTT, Maastricht Instruments BV, Maastricht, 
the Netherlands). Both parameters were measured by means of a 
finger cuff that was connected to a cardiovascular monitor (Nex-
fin, BMEYE BV, Amsterdam, the Netherlands). All measure-
ments were acquired with custom-made software (IDEEQ, 
Maastricht Instruments BV, Maastricht, the Netherlands).
Study 2: PD patients
Subjects. One-hundred and eighty-three Caucasian PD patients 
(mean age 36.14 years, SD = 10.94; 71 men) participated in this 
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study. Patients were recruited from the outpatient setting of the 
Academic Anxiety Centre, Maastricht, the Netherlands. PD (with 
or without agoraphobia) as main diagnosis was established via a 
semi-structured psychiatric interview by an experienced psychia-
trist, including the MINI (Sheehan et al., 1998) (see assessment 
scores shown in Supplementary table 1 online). Patients under-
went a standard medical examination to confirm eligibility. 
Exclusion criteria were current or past cardiovascular or pulmo-
nary disease, hypertension (systolic/diastolic >170/100 mmHg), 
familial or personal history of cerebral aneurysm, pregnancy, and 
epilepsy. In total, 106 patients had one or more comorbid disor-
ders. Patients were free of antidepressant and benzodiazepine 
treatment for at least 4 or 2 weeks, respectively, before taking 
part in the experiment. Written informed consent was obtained 
from each subject before participating. The study was approved 
by the Medical Ethics Committee of Maastricht University and 
the Maastricht University Hospital.
CO2 inhalation. In PD patients, CO2 inhalations took place 
according to a standardized protocol as described previously 
(Klaassen et al., 1998). Subjects were informed that the subse-
quent inhalation might cause some effects, ranging from minor 
sensations up to fear. However, all effects would be short-lasting. 
Subjects took a single vital capacity breath of 35% CO2. Using a 
flowmeter it was ensured that at least 80% of their previously 
measured vital capacity was inhaled.
Self-reports. In line with the DSM-IV criteria for a PA (Ameri-
can Psychiatric Association, 2000), experienced fear was evalu-
ated using the Visual Analogue Scale for fear (VAS-F), 
consisting of a horizontal line of 100 mm length and ranging 
from 0 (not at all) to 100 (the worst imaginable). Panic symp-
toms were assessed by means of the PSL, a questionnaire listing 
the 13 DSM PA symptoms, and ranging from 0 (absent) to 4 
(very intense). Self-reports were obtained directly before and 
immediately after the inhalation.
Genotyping
Saliva was collected from all subjects using Oragene® saliva 
self-collecting kits (DNA Genotek Inc, Ontario, Canada). 
Genomic DNA was isolated using the AutoGenFlex DNA 
Isolation system (Autgen, Hilliston, MA, USA) according to 
manufacturer’s instructions and subsequently genotyped using 
Taqman SNP Genotyping Assays for rs10875995 and rs685012 
(Life Technologies). The selection of these particular polymor-
phisms was based on the results of the recent study by Smoller 
et al. (2014), in which an association with PD and amygdala reac-
tivity was found. Results were independently scored by two 
experienced technicians.
Data and statistical analysis
Primary analyses. Differences in the change of self-reported 
emotions and symptoms depending on the genotype were ana-
lyzed using univariate analysis of variance (ANOVA). Six PD 
patients were excluded from the rs685012 analysis due to 
genotyping failure (final sample mean age 36.14 years, SD = 
10.94; 71 men).
To analyze physiological measurements in healthy subjects, 
locally weighted polynomial regression (Cleveland and Devlin, 
1988) was used to avoid strong effects of outliers. Based on 
smoothed data, the maximum, the area under the curve (AUC), 
and the standard deviation (log transformed) were calculated 
within the first 60 s after inhaling CO2. The maximum represents 
the highest value/peak in this period, which might reflect a few 
seconds of the response only. To capture the response in more 
detail, the AUC was calculated. The standard deviation serves as 
index for fluctuations caused by CO2. Due to a technical failure, 
the final sample for physiological analyses consisted of 92 sub-
jects (mean age 23.56 years, SD = 0.44; 24 men).
Secondary analysis. Patients with predominantly respiratory 
symptoms during their PAs have been proposed as forming a 
“core” panic subtype (Roberson-Nay and Kendler, 2011). 
Smoller et al. (2014) showed a particularly strong relationship 
between ACCN2 genotype and such a respiratory panic subtype. 
We have previously demonstrated the existence of a similar 
respiratory subtype in response to a CO2 challenge (Colasanti 
et al., 2008). Analysis of the respiratory cluster was based on this 
previous cluster analysis study (Colasanti et al., 2008) and con-
sisted of the symptoms shortness of breath, feeling of choking, 
dizziness, sweating, palpitations, and chest pain. The effect of 
genotype on the sum of the change scores of these six symptoms 
was analyzed by means of univariate ANOVA.
Based on Smoller et al. (2014), C-allele carriers were com-
pared to T/T homozygotes in all analyses for both polymor-
phisms. Significance was set at p < 0.05. All analyses were 
performed using the Statistical Package for the Social Sciences 
(SPSS 20.0.0.1 for Mac; SPSS Inc., Chicago, IL) or the soft-
ware R (version 3.1.1, 2014, R Development Core Team, 
Vienna/Austria).
Results
Demographical data of healthy volunteers and PD patients are 
presented in Table 1. The distribution of ACCN2 genotypes was 
in Hardy–Weinberg equilibrium for both samples. Genotypes did 
not differ with respect to sex and age and the duration of PD.
Study 1: Healthy volunteers
Self-reports to CO2 inhalation. In healthy volunteers, no effect 
of the rs10875995 genotype on the change score regarding 
VAS-F (p = 0.264, Figure 1(a)), VAS-D (p = 0.208), and PSL (p 
= 0.196, means shown in Supplementary table 2) was present. No 
rs685012 genotype effect was found on VAS-F (p = 0.646, Figure 
2(a)), VAS-D (p = 0.131), and PSL ratings (p = 0.453, means 
shown in Supplementary table 3).
Cardiovascular response to CO2 inhalation. Healthy subjects 
homozygous for the T-allele of rs10875995 showed a signifi-
cantly higher AUC (p = 0.043, means shown in Supplementary 
table 4) and a tendency towards a higher peak (p = 0.089) of the 
systolic blood pressure after the CO2 inhalation. Similarly, also 
the AUC (p = 0.049, Figure 3(a)) and the peak (p = 0.030, Figure 
3(b)) of the diastolic blood pressure were elevated after inhaling 
CO2 compared to C-allele carriers. No effect was found on any 
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Table 1. Demographics of healthy volunteers and PD patients.
rs10875995 rs685012
 C/C and C/T T/T C/C and C/T T/T
Healthy
volunteers
N 55 52 56 51
Sex (% male) 21 29 20 30
Age (SD) 23.70 (7.02) 23.83 (7.22) 24.04 (7.17) 23.45 (6.78)
PD patients N 90 93 91 86
Sex (% male) 40 38 36 42
Age (SD) 36.06 (11.55) 36.22 (10.37) 36.18 (11.63) 36.31 (10.36)
Duration PD (years (SD)) 11.08 (11.30)  8.82 (9.84) 11.12 (11.31)  9.05 (10.07)
Figure 1. Effects of CO2 on the VAS-F ratings depending on the rs10875995 genotype. (a) No effect of genotype on the VAS-F was found in healthy 
subjects. (b) In PD patients, homozygous T-allele carriers scored significantly higher than C-allele carriers. *p < 0.05. Data represent mean + SEM.
Figure 2. Effects of CO2 on the VAS-F ratings depending on the rs685012 genotype. (a) No effect of genotype was present in healthy subjects. (b) 
In PD patients, a trend towards a higher change score was found in carriers homozygous for the T-allele in comparison with C-allele carriers. #0.05 < 
p <0.1. Data represent mean + SEM.
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outcome of heart rate (AUC p = 0.357, peak p = 0.698). With 
regard to rs685012, no effect was present on any outcome (Sup-
plementary table 5).
Study 2: PD patients
Self-reports to CO2 inhalation in PD patients. In PD patients, 
subjects homozygous for the rs10875995 T-allele scored signifi-
cantly higher on the VAS-F in comparison with C-allele carriers 
(p = 0.032, Figure 1(b), means shown in Supplementary table 2), 
whilst no effect of genotype on reported PSL scores was found (p 
= 0.388). With regard to rs685012, there was a trend towards 
higher VAS-F ratings in subjects with the T/T genotype in com-
parison with C-allele carriers (p = 0.061, Figure 2(b)). No signifi-
cant effect of ACCN2 genotype on PSL scores was observed (p = 
0.519, means shown in Supplementary table 3).
Secondary analysis. Respiratory cluster analysis. We next 
analyzed the effect of genotype on the respiratory symptom 
cluster in the response to the CO2 challenge, as defined in a 
previous study. There was no main effect of rs10875995 (p = 
0.659) or rs685012 genotype (p = 0.889) (means shown in 
Supplementary tables 2 and 3).
Discussion
In this study, we show an association between two genetic vari-
ants in the ACCN2 gene, selected based on prior data (Smoller 
et al., 2014), and CO2 sensitivity in PD patients and healthy indi-
viduals. More specifically, the rs10875995 T/T genotype was 
associated with higher fear scores in patients, and with a higher 
blood pressure response to a CO2 panic challenge in healthy sub-
jects compared to C-allele carriers.
The ACCN2 gene is the human orthologue of the rodent gene 
encoding the pH-sensitive ion channel ASIC1a, which was 
shown to be critically involved in conditioned (Wemmie et al., 
2003, 2004) as well as unconditioned CO2-induced fear behavior 
in mice (Ziemann et al., 2009). Therefore, ASIC1a is a prime 
candidate to be involved in the molecular pathophysiology of 
panic in humans. To date, the few previous human studies inves-
tigating an association between the ACCN2 gene and PD reported 
an association of the rs685012 and/or rs10875995 C-allele with 
PD or anxiety disorders (Gugliandolo et al., 2016; Hettema et al., 
2008; Smoller et al., 2014). Smoller and colleagues also found a 
larger amygdala volume and heightened functional amygdala 
reactivity in a sample of healthy C-allele carriers of the 
rs10875995 genotype. The authors suggested that this observed 
amygdala-association might reflect an increased sensitivity to a 
decrease in pH, secondary to neuronal activity to process the 
visual emotional stimulus. The elevated sensitivity would be 
associated with ACCN2 gene variants that contribute to a 
decreased threshold for sensing acidosis. Furthermore, they spec-
ulated that “such activation would clearly be less direct (and less 
intense) than that induced by a direct CO2 inhalation.”
The present studies show an rs10875995 genotype effect on 
the emotional as well as cardiovascular reactivity following such 
a direct 35% CO2 inhalation. In PD patients, VAS-F ratings were 
higher in carriers homozygous for the rs10875995 T-allele com-
pared to C-allele carriers and consistent with this we also found a 
heightened cardiovascular response in healthy T/T carriers. This 
is in contrast to the study by Smoller et al. (2014), in which the 
C-allele was considered as risk allele. This might be explained by 
focusing on different phenotypes. In Smoller’s study, the C-allele 
was shown to be associated with the diagnosis of PD and with 
amygdala volume and function, i.e. largely anxiety-related endo-
phenotypes, whereas the present study showed a relationship 
between the T-allele and experimentally provoked fear/panic sen-
sations, i.e. specific fear-related endophenotypes. The amygdala 
has been implicated in rodent (Ziemann et al., 2009) and human 
(Holmes et al., 2012) fear behavior as well as in enhanced reac-
tivity to emotional threats in humans (Shin and Liberzon, 2010). 
Furthermore, altered amygdala structure and functioning has 
been reported in PD patients (Kim et al., 2012). However, PD is 
a complex disorder and consists of different aspects (PAs, antici-
patory anxiety, and avoidance behavior), which are likely 
Figure 3. Effects of the rs10875995 genotype on the diastolic blood pressure in response to CO2 in healthy subjects. (a) Homozygous T-allele 
carriers had a significantly higher AUC after inhaling CO2 compared to subjects of the C/C and C/T genotype. (b) The same effect was observed with 
regard to the peak after inhaling CO2. *p < 0.05. Data represent mean + SEM.
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subserved by different parts of the brain and not solely by the 
amygdala. While the amygdala may be most important in the 
conditioning process leading to avoidance behavior, the nature of 
PAs might be more related to other structures such as the brain-
stem (Goossens et al., 2014). Therefore, focusing on a complex 
anxiety disorder (diagnosis of PD) or a fear-specific phenotype 
(response to CO2) might lead to different results.
Moreover, observing opposite alleles associated with risk dis-
ease between studies is a known phenomenon in association 
studies and is referred to as “flip-flop phenomenon” (Lin et al., 
2007). Although the exact cause is unknown it is assumed that it 
occurs when the focus is on one genetic locus while in fact many 
genetic variants or environmental factors, and their mutual inter-
action, contribute to complex phenotypes such as neuropsychiat-
ric disorders. In addition, in spite of similar ethnicities, two 
populations can differ in terms of linkage disequilibrium between 
the two genetic loci, leading to differences in the direction of the 
association between studies (Lin et al., 2007). Moreover, Clarke 
and Cardon (2010) have calculated that the probability of finding 
at random flip-flop associations is negligible. Therefore, this 
phenomenon may have biological implications.
Given that PAs are accompanied by profound physiological 
symptoms, we also included cardiovascular measurements in 
healthy volunteers to complement self-reports. Consistent with 
an elevated emotional response in patients of the rs10875995 T/T 
genotype, we found a heightened cardiovascular response in 
healthy T/T carriers. It has been shown that ASIC1a interacts 
with ASIC2, a channel implicated in baroreceptor sensitivity and 
thus blood pressure regulation (Lu et al., 2009). In addition, inter-
action of the two channels can shift the pH sensitivity (Wemmie 
et al., 2013). Currently, the functional consequences of variants 
in the ACCN2 gene are not known. It might be speculated that the 
T-variant increases the pH sensitivity, associated with an elevated 
autonomic response. In addition to cardiovascular symptoms, 
respiratory ones are common during PAs. PAs with prominent 
respiratory symptoms have been proposed as a core panic sub-
type (Roberson-Nay and Kendler, 2011) and Smoller et al. (2014) 
showed a particularly strong association between the ACCN2 
genotype and the respiratory subtype in a secondary analysis. We 
could not confirm this in the present study, possibly due to meth-
odological differences between the studies. We based our defini-
tion of a respiratory subtype on a cluster of six PSL sub-items in 
response to the CO2 inhalation, that we previously identified 
using a principal component factor analysis (Colasanti et al., 
2008), whilst Smoller et al. (2014) grouped patients depending 
on the predominance of certain symptoms during real-life PAs, 
assessed via diagnostic interview. On the molecular level, the 
role of ASIC1a in respiration is still under investigation, but 
ASIC1a knock-out mice that do not express the protein were 
shown to have normal increases in minute ventilation to CO2 
(Ziemann et al., 2009).
It has to be noted that we did not observe all effects consist-
ently in both human samples. While patients having the T-allele 
of rs10875995 showed an increased fear response to CO2, no 
effect was found in healthy volunteers. We have previously 
reported that a double vital capacity inhalation of 35% CO2 in 
healthy volunteers induced a condition complying with the for-
mal criteria of panic in the current psychiatric nosology (Griez 
et al., 2007). However, this constitutes a qualitative comparison; 
recently we provided a direct quantitative comparison showing 
that PD patients on average still show a higher sensitivity to CO2 
(Leibold et al., 2016). This might explain, together with the 
smaller sample size in the healthy group, why the effect of 
genetic variation can be detected more easily in patients. Further, 
in patients, a moderating effect of the ACCN2 genotype on VAS 
scores, but not on reported bodily symptoms, may be explained 
by the finding that the VAS is a more specific instrument than the 
PSL to measure reactivity to a 35% CO2 challenge (Battaglia and 
Perna, 1995; Verburg et al., 1998). Similar effects were found for 
rs685012.
In light of the current theories about the pathophysiology of 
PD, we have proposed that PAs are caused by an acute metabolic 
disturbance of the acid–base homeostasis (Esquivel et al., 2009). 
Such a metabolic disturbance might form the molecular basis of 
Klein’s suffocation false alarm theory (Klein, 1993; Preter and 
Klein, 2008) and can be induced by inhaling CO2. In rodents, it 
has been shown that ASICs are important in detecting and trig-
gering behavioral responses to CO2 (Ziemann et al., 2009). The 
present study and the ones in the past few years that show an 
association between ASIC and PD (phenotypes) suggest that 
these channels might be one of the neural substrates in the alarm 
system in humans.
ASIC1a is expressed throughout the entire central nervous 
system including the brainstem (Price et al., 2014) and is a 
likely molecular candidate to act as chemosensor in a variety of 
neurons. Neurons intrinsically sensitive to CO2/pH are located 
within many brain structures (Biancardi et al., 2008; da Silva 
et al., 2011; Dean et al., 1990; Mulkey et al., 2004; Putnam 
et al., 2004; Ziemann et al., 2009). Some of those structures 
most likely serve different functions such as breathing as well 
as defensive behavior (Esquivel et al., 2009). The exact contri-
bution of these brain structures in CO2 sensitivity, sensing 
changes in pH and eliciting a fear and panic-related behavioral 
response, is still elusive. In rodents, the amygdala has been 
identified as an essential brain structure in this process (Ziemann 
et al., 2009), while research in Urbach–Wiethe disease patients 
having a bilaterally dysfunctional amygdala could not confirm 
this (Feinstein et al., 2013). A recent functional magnetic reso-
nance imaging study by our group (Goossens et al., 2014) sug-
gests that, at least in humans, the brainstem is the principal 
brain area in sensing changes in CO2/pH.
Future studies should address the relationship between vari-
ants in the ACCN2 gene and the locus of brain activity in response 
to CO2 in a large sample. In addition, the functional consequences 
of those variants should be investigated. This is also interesting in 
relationship to cardiovascular and respiratory measures in 
patients, which we did not assess in the present study. Further, the 
exact effects of inhaling CO2 on brain pH in humans remain to be 
elucidated. In rodents, it was shown that exposure to CO2 
decreases brain pH (Ziemann et al., 2009). In humans however, 
direct evidence for such a CO2-induced brain acidosis is lacking. 
Indirect evidence is available, provided by MRI studies showing 
that PD patients have a larger brain lactate response to visual 
stimuli (Maddock et al., 2009) and after lactate infusion (Dager 
et al., 1997, 1999), compared to healthy controls. Work in rodents 
showed that an increase in lactate causes a decrease in brain pH 
(Erlichman et al., 2008), suggesting that a similar effect may 
occur in humans. Combining CO2 administration and MR spec-
troscopy, able to non-invasively detect brain pH changes, may 
provide the lacking direct evidence.
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Limitations
The results of this study should be interpreted keeping in mind 
some potential limitations. First, the sample size of the present 
study is relatively small for genetic analyses. Due to the low 
number of subjects homozygous for C, we clustered C-allele car-
riers into one group to allow meaningful statistical analyses 
instead of a possibly more sensitive quantitative (0-1-2 alleles) 
approach. Second, we did not correct for multiple testing, given 
our confirmatory and clear hypothesis-driven approach of two 
highly correlated variants. Third, family history of PD was an 
exclusion criterion in the healthy volunteers group. With hind-
sight, this may have led to the inclusion of a “hyper-normal” 
group, thereby increasing the possibility of a type II error. This 
might explain the less homogeneous results in the healthy group. 
To increase the sensitivity on outcome measurements, future 
studies should include samples with a larger variation in anxiety, 
such as individuals with differential anxiety sensitivity or first-
degree relatives of PD patients.
Conclusion
The results of the present study extend on those of previous studies 
into the mechanisms of panic and provide the first evidence for a 
relationship between the ACCN2 gene and the reactivity to a CO2 
panic challenge in humans. Thereby, the association between the 
ACCN2 gene and PD is strengthened and the importance of inves-
tigating both the role of variants in the ACCN2 gene in humans as 
well as ASIC1a in rodents in the pathophysiology of panic is fur-
ther supported. In the long-term, ACCN2 may become a potential 
therapeutic target in the treatment of PD, a suggestion that is also 
supported by rodent research in which pharmacological inhibition 
of ASIC1a reduced fear-behavior (Ziemann et al., 2009).
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